Back
Roivant Sciences Vs. Biodexa Pharmaceuticals Plc Industry Stock Comparison
Buy
55
ROIV
Roivant Sciences
Last Price:
11.23
Seasonality Move:
18%
Sell
47
BDRX
Biodexa Pharmaceuticals Plc
Last Price:
1.18
Seasonality Move:
-17.41%
Buy
55
Roivant Sciences (ROIV)
is a Buy
Is Roivant Sciences a Buy, Sell or Hold?
- The current Roivant Sciences [ROIV] share price is $11.23. The Score for ROIV is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- ROIV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
Biodexa Pharmaceuticals Plc (BDRX)
is a Sell
Is Biodexa Pharmaceuticals Plc a Buy, Sell or Hold?
- The current Biodexa Pharmaceuticals Plc [BDRX] share price is $1.19. The Score for BDRX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- BDRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ROIV Stock Price Chart
What is Roivant Sciences's stock price today?
-
The Roivant Sciences share price today is $11.23
The current trend is moderately bullish and ROIV is experiencing slight buying pressure.
BDRX Stock Price Chart
What is Biodexa Pharmaceuticals Plc's stock price today?
-
The Biodexa Pharmaceuticals Plc share price today is $1.19
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BDRX is experiencing selling pressure, which indicates risk of future bearish movement.
ROIV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.12 | Buy |
Relative Strength Index (14 RSI): | 52.25 | Buy |
Chaikin Money Flow: | 731262 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.72 - 11.38) | Buy |
Bollinger Bands (100): | (10.38 - 11.46) | Buy |
BDRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 54.79 | Buy |
Chaikin Money Flow: | -343429 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.82 - 1.24) | Buy |
Bollinger Bands (100): | (0.93 - 1.95) | Sell |
ROIV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.28 | Sell |
20-day SMA: | 11.17 | Buy |
50-day SMA: | 10.86 | Buy |
200-day SMA: | 10.63 | Buy |
8-day EMA: | 11.3 | Sell |
20-day EMA: | 11.19 | Buy |
50-day EMA: | 11.02 | Buy |
200-day EMA: | 10.42 | Buy |
BDRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.07 | Buy |
20-day SMA: | 1.08 | Buy |
50-day SMA: | 1.07 | Buy |
200-day SMA: | 2.89 | Sell |
8-day EMA: | 1.12 | Buy |
20-day EMA: | 1.09 | Buy |
50-day EMA: | 1.17 | Buy |
200-day EMA: | 37.48 | Sell |
Roivant Sciences Earnings Growth & ROIV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.22 per share.
Biodexa Pharmaceuticals Plc Earnings Growth & BDRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.03 per share.
Roivant Sciences Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Biodexa Pharmaceuticals Plc Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |